EU Recommends Approval for Alexion's Rare Disease Drugs

News   Jun 30, 2015

 
EU Recommends Approval for Alexion's Rare Disease Drugs
 
 
 

RELATED ARTICLES

Mechanism of ApoE4 Gene Toxicity in Alzheimer's Disease Neurodegeneration Solved

News

ApoE4 exacerbates the brain damage caused by toxic tangles of Alzheimer's-associated protein, tau.

READ MORE

Drug Discovery Alliance Formed to Help Increase Drug Development Success Rate

News

Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.

READ MORE

Innovative Chromatography Technologies to be Discussed at Preconference Workshop

News

Biopharmaceutical researchers from around the globe will discuss innovative chromatographic approaches and technologies for purifying diverse biomolecules during a preconference workshop sponsored by Bio-Rad Laboratories, Inc.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE